Clinical Trials Browser

NIH × Interventional × Bone Diseases, Metabolic × Clear all

Bone Diseases, Metabolic, Neoplasms, Vascular Diseases

NCT01447914 2019-08-28

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Classical hematologyOther hematologic neoplasmPlasma cell

Amyloidosis, Anemia, Bone Diseases, Metabolic, Fractures, Spontaneous, Hypercalcemia, Multiple Myeloma, Osteolysis, Paraproteinemias, Hematologic Neoplasms, Renal Insufficiency

Clinical Trials

Translational Development of Photon-counting CT Imaging

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma